Skip to content

Demystifying Global Business.

These drug patents are expected to expire in 2020

According to a report, drugmakers are expected to lose $17 billion in worldwide sales due to patent expirations this year. <ClickHere>

Author globestrategyPosted on 13 Apr 20209 Aug 2021Categories Business contactsTags patent cliff

Post navigation

Previous Previous post: Coronavirus highlights the $35 billion vaccine market. Here are the key players

Next Next post: Biosimilar Market: The Future for the Generic Pharmaceuticals Industry

Why Climate Change fails?
Michael Porter – Strategy
Deloitte’s Transfer Pricing practice
OECD Transfer Pricing
Transfer Pricing

A collection of writing and thoughts on global issues
About Globestrategy
Academic Theory and Frameworks
Acknowledgement
Andragogy, Pedagogy and Research in the Global Strategy space
Business Resources for new markets
Contact
Country Risk Profiling
Country/Markets Signposts
Creating the entry strategy
Defining Global strategy
Defining Global Strategy
Defining Global Strategy at the Firm Level
Disruptions impacting global business
Free Books on Business
Free Trade Agreements
Free Trade agreements databases
GlobeStrategy on Instagram
glossary
Glossary of terms used in International Business
Learning@Globestrategy
Media files
Musings and Ramblings on Global Strategy
NHS Management Day Training for Higher Surgical Trainees
Open Business Data Sources
Resources Business StartUps to go Global.
Resources for Teachers
The Global Strategy Landscape
The Globalisation debate
The history of Global Trade
Theory behind Global Strategy
Tools and Resources centre
Training Resources
Using the site

Globestrategy Defining Global strategy Curated by suresh george

Loading...